
HBANP · Nasdaq
There is no analyst consensus for HBANP: the supplied data show zero analysts and no low, mean, or high price targets. No HBANP-specific rating revisions were reported during the past week, and the evidence does not identify a most or least bullish analyst for the preferred shares. The only attributable actions concern Huntington's common stock. Bank of America downgraded HBAN from Buy to Neutral and cut its target to $18.50 from $20, making it the less bullish view, while Baird analyst David George raised his target to $21 from $20 and retained Outperform, making it the more bullish view. Their disagreement concerns common-equity prospects, not a stated HBANP valuation.